News, Stories, Guidelines, Opinions, History

“African-American women less likely to receive evidence-based care for endometrial cancer”

“Even if African-American women receive evidence-based care, it may mitigate but does not completely eliminate the survival disparities that we saw based on race,” says Jason D Wright (above) of Columbia University’s Herbert Irving Comprehensive Cancer Center in New York. “We still need to work and look at other factors that may be responsible for the survival disparities that we see.”

Wright and his colleagues reviewed the cases of 310,000 U.S. women treated for endometrial cancer from 2004 through 2016 to see whether the women received evidence-based care, which is linked to an improved prognosis. Black women were less likely than White women to receive the recommended care, but even they did  receive similar treatment, Black woman were still more likely than White women to die within 5 years.

“We still have a lot of work that needs to be done to better understand why there’s this discrepancy in survival,” says Wright. “What we have seen is not completely due to the quality of care that African-American women are receiving.”

Endometrial cancer is typically a cancer that’s highly curable with early detection and appropriate treatment, Wright points out. “To see the survival disparities with a highly curable cancer is particularly problematic. We need to address that so we can have a higher percentage of women with this cancer who can be treated appropriately, and hopefully cured.”

Scroll to Top